← Back to Analyst Consensus 
UNCY Buy
Unicycive Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 29, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 20, 2026 | Benchmark | maintain | Speculative Buy → Speculative Buy | — | 54% |
| Aug 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 13, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 54% |
| Jul 1, 2026 | Benchmark | maintain | Speculative Buy → Speculative Buy | — | 54% |
| Jul 1, 2026 | Noble Capital Markets | maintain | Outperform → Outperform | — | 63% |
| Jun 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 30, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 54% |
| Jun 2, 2026 | Benchmark | maintain | Speculative Buy → Speculative Buy | — | 54% |
| May 13, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Apr 6, 2026 | Benchmark | maintain | Speculative Buy → Speculative Buy | — | 54% |
| Apr 2, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Oct 29, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $22 | 44% |
| Sep 15, 2025 | Benchmark | maintain | Speculative Buy → Speculative Buy | $21 | 54% |
| Apr 21, 2025 | Guggenheim | initiate | — → Buy | $6 | 52% |
| Apr 11, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7.5 | 44% |
| Apr 1, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $7.5 | 44% |
| Jan 29, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $4 | 44% |
| Jan 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Nov 22, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| Nov 14, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $4 | 44% |
| Nov 12, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $2.5 | 44% |
| Oct 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $2.5 | 44% |
| Sep 6, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| Sep 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $2.5 | 44% |
| Aug 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $2.5 | 44% |
| Jul 10, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Jun 25, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Jun 3, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| May 31, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| May 29, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| May 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Apr 15, 2024 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| Apr 4, 2024 | Piper Sandler | initiate | — → Overweight | $9 | 54% |
| Apr 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Mar 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Mar 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Mar 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Feb 14, 2024 | Noble Capital Markets | initiate | — → Outperform | $6 | 63% |
| Dec 19, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $4.5 | 44% |
| Dec 4, 2023 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| Aug 16, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $4.5 | 44% |
| Jul 19, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jun 30, 2023 | EF Hutton | reiterate | Buy → Buy | $5 | 30% |
| Jun 30, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Jun 26, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| Jun 20, 2023 | Benchmark | reiterate | Speculative Buy → Speculative Buy | $3 | 54% |
| May 17, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $8 | 44% |
| May 17, 2023 | EF Hutton | reiterate | Buy → Buy | $5 | 30% |
| Apr 21, 2023 | Benchmark | maintain | Speculative Buy → Speculative Buy | $3 | 54% |
Price Target Trend
Mar 30, 2026 Oct 26, 2026
EPS Estimates
0q —
+1q —
0y —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days